The Council of Scientific & Industrial Research (CSIR) and Nature India have launched the Nature India ess...Read more
TCG Lifesciences, a company promoted by New York based Purnendu Chatterjee Group, has announced the induction ...Read more
The CSIR-Institute of Microbial Technology (IMTECH) conducted a five-day workshop on the fundamentals of Ferme...Read more
Step in with Caution
A major transformation started coming around in 2019 in the form of the fourth industrial revolution, Industry 4.0. It has gradually gained momentum as a blend of advanced analytics, Big Data, Robotics & Automation, Artificial Intelligence, Internet of Things (IoT) and Process Digitisation across the healthcare business value chain. Pharma, medical device and biotechnology innovators are harnessing digital technology and the power of big data and advanced analytics to deliver a more cost effective approach to healthcare in 2020. However, there lies a word of caution for the pharma industry particularly with respect to the aftermath of US-China trade tensions and the upcoming US elections in 2020. This requires the industry to take appropriate and careful steps to ensure the targeted growth.